Commercial Credit Report for Caplin Point Laboratories Ltd (Parent)

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Caplin Point Laboratories Ltd (Parent) is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Caplin Point Laboratories Ltd (Parent)
Narbavi
No. 3, Lakshmanan Street,, T. Nagar,
Phone: +91 4428156653p:+91 4428156653	CHENNAI, 600096 India	Fax: +91 4428154952f:+91 4428154952

Business Summary

Caplin Point Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in producing, developing, and marketing a range of generic formulations and branded products and exporting to overseas markets. Its products include tablets, dry syrups (bottles), soft gels, capsules, suppositories, liquid syrups (bottles), liquid injectables in ampoules and vials, lyophilized vials, prefilled syringes (PFS), emulsion injection in ampoules and vials, ophthalmic droppers, pre-mix bags, topicals and sachets (liquids and powders). It also manufactures a range of ointments, creams, gels and lotions. Its principal research and development facilities are in Tamil Nadu, India. Its principal manufacturing facility is in Puducherry, India. It has presence in Latin America (LATAM), Southern Africa and Francophone Africa along with a presence in United States of America and European region. The Company’s subsidiaries include Caplin Point Far East Limited and Caplin Steriles Limited.

(Source: ARS)

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
-	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
6/30/2023	3/31/2022	Yes	-	-	-	-

Industries

SIC Code	Description
2834	Pharmaceutical preparations

Officers and Directors

Title	Name	Age	Title Date	Start Date
Non-Executive Chairman of the Board	Chingelput C.Paarthipan	71		10/1/1993
Chief Financial Officer	D.Muralidharan	67	2/19/2016	2/19/2016
Compliance Officer, General Counsel, Company Secretary	G.Venkatram	41	1/1/2023	8/5/2022
5 additional Officers and Directors records available in full report.

General Information

Outstanding Shares:	75,939,746	(As of 9/11/2023)
Fax Number:	+91 4428154952

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN